期刊文献+

垂体生长激素腺瘤中gsp癌基因对GHSR-1a、Ghrelin mRNA表达的影响

Effect of gsp oncogene on expression of GHSR - la and Ghrelin mRNA in human GH - secreting pituitary adenomas
原文传递
导出
摘要 目的 研究垂体生长激素(GH)腺瘤组织中Ghrelin、生长激素释放剂受体-1a亚型(GHSR-1a)mRNA的表达,并探讨其表达与gsp癌基因的关系.方法 采用PCR-DNA直接序列分析方法,观察43例垂体GH腺瘤组织中gsp癌基因的表达;应用实时荧光定量PCR检测Ghrelin和GHSR-1a mRNA的表达水平;统计学分析Ghrelin和GHSR-1a mRNA表达与gsp癌基因的关系.结果 Ghrelin mRNA表达在gsp癌基因阳性、阴性组织间差异无统计学意义(P>0.05);gsp阳性组织中GHSR-1a mRNA表达明显高于gsp阴性组织(P<0.05);gsp阳性、阴性腺瘤组织中GHSR-1amRNA与Ghrelin mRNA的表达均呈明显正相关(R=0.592或0.544,P<0.05).结论 垂体GH腺瘤中gsp癌基因上调GHSR-1a mRNA的表达;而对Ghrelin mRNA表达无明显影响.gsp阳性、阴性腺瘤中Ghrelin均可正向调控GHSR-1a mRNA表达. Objective To investigate the relationship between the expression of growth hormone secretagogue receptor type 1a (GHSR- 1a) 、Ghrelin mRNA and gsp oncogene in human GH- secreting pituitary adenomas. Methods The gsp oncogene mutation in 43 cases of GH -secreting pituitary adenomas was detected by PCR - DNA direct sequencing analysis. The expression of GHSR - 1a、Ghrelin mRNA was determined by SYBR green real -time fluorescent quantitative PCR. Then the relationships between the expression of GHSR -1a、Ghrelin mRNA and gsp oncegene were studied with statistical methods. Results There was no significant difference in the expression of ghrelin mRNA between mutation - positive and mutation - negative adenomas. The expression of GHSR - 1a mRNA was significantly higher in gsp - positive adenomas than that in gsp - negative adenomas. There was significant direct correlation between the levels of ghrelin mRNA and GHSR mRNA expression in gsp - positive and gsp - negative adenomas. Conclusions Gsp oncogene may up - regulate the expression of GHSR - 1a mRNA and has no effect on the expression of ghrelin mRNA in human GH - secreting pituitary adenomas. In addition, ghrelin could elevate the expression of GHSR - 1a mRNA in GH - secreting pituitary adenomas with or without gsp mutations.
出处 《中华神经外科杂志》 CSCD 北大核心 2010年第8期726-730,共5页 Chinese Journal of Neurosurgery
基金 国家自然科学基金资助项目(30672161)
关键词 Gsp癌基因 GHSR—1a GHRELIN Gsp oncogene GHSR - 1a Ghrelin
  • 相关文献

参考文献13

  • 1Lei T,Adams EF,Buchfelder M,et al.Relationship between protein kinase C and adenylyl cyclase activity in the regulation of growth hormone secretion by human pituitary somatotrophinomas.Neurosurgery,1996,39:569-575.
  • 2白祥军,雷霆,刘暌,薜德麟.gsp癌基因在国人肢端肥大症患者垂体肿瘤中的表达[J].中华实验外科杂志,2000,17(1):53-54. 被引量:13
  • 3Kim K,Arai K,Sanno N,et al.Ghrelin and growth hormone (GH) secretagogue receptor (GHSR) mRNA expression in human pituitary adenomas.Clin Endocrinol (Oxf),2001,54:759-768.
  • 4Kineman RD,Kamegai J,Frohman LA.Growth hormone (GH)-releasing hormone (GHRH) and the GH secretagogue (GHS),L692,585,differentially modulate rat pituitary GHS receptor and GHRH receptor messenger ribonucleic acid levels.Endocrinology,1999,140:3581-3586.
  • 5Korbonits M,Bustin SA,Kojima M,et al.The expression of the growth hormone secretagogue receptor ligand ghrelin in normal and abnormal human pituitary and other neuroendocrine tumors.J Clin Endocrinol Metab,200t,86:881-887.
  • 6李向东,周和平,惠国桢,郭凌川,于晶,惠卫宁.Ki-67、MMP-9蛋白表达与垂体腺瘤侵袭性的相关性研究[J].中华神经外科杂志,2008,24(10):762-764. 被引量:6
  • 7Sakai N,Kim K,Sanno N,et al.Elevation of growth hormonereleasing hormone receptor messenger ribonucleic acid expression in growth hormone-secreting pituitary adenoma with Gsalpha protein mutation.Neurol Med Chir (Tokyo),2008,48:481-487;discussion 487 -488.
  • 8Adams EF,Brockmeier S,Friedmann E,et al.Clinical and biochemical characteristics of acromegalic patients harboring gsppositive and gsp-negative pituitary tumors.Neurosurgery,1993,33:198-203.
  • 9李俊,徐同江,叶飞,曾亮,王胜,雷霆.Ghrelin/GHS—R1a对鼠GH3细胞株增殖的影响及其作用机制[J].中华实验外科杂志,2009,26(9):1093-1095. 被引量:3
  • 10张华楸,王雄伟,范月超,王和平,叶飞,雷霆.“交叉通讯”在人垂体生长激素腺瘤激素分泌中的调控作用研究[J].微循环学杂志,2005,15(2):11-14. 被引量:4

二级参考文献30

  • 1李洛,王智兰,雷霆.GHRP-6对培养的垂体生长激素腺瘤和正常胚胎垂体细胞促GH分泌特征[J].青岛医药卫生,2004,36(1):4-6. 被引量:1
  • 2杨军,杨福义,廉晓宇,王彩霞,王晓.血管内皮细胞生长因子和增殖细胞核抗原表达与垂体腺瘤侵袭性的关系[J].中华神经外科杂志,2005,21(9):568-570. 被引量:4
  • 3任祖渊.蝶鞍部肿瘤.见:王忠诚主编.王忠诚神经外科学.武汉:湖北科学技术出版社,2005:620-651.
  • 4Hardy J, Vezina JL. Transsphenoidal neurosurgery of intracranial neoplasm. Adv Neurol, 1976,15:261-273.
  • 5Knosp E, Steiner E, Kitz K, et al. Pituitary ademomas with invasion of the cavernous sinus space: a magnetic resonance inaging classification compared surgical fingdings. Neurosurgery, 1993,33:610-618.
  • 6Thapar K, Kovacs K, Scheitbauer BW, et al. Proliferative activity and invasiveness among pituitary adenomas and carcinomas: an analysis using the MIB-1 antibody. Neurosurgery, 1996, 38: 99-106.
  • 7Turner HE, Nagy Z, Esiri MM, et al. Role of matrix metalloproteinase 9 in pituitary tumor behavior . Clin Endocrinol Metab, 2000,85:291-295.
  • 8Kawamoto H, Vozumi T, Kawammoto K. Type Ⅳ Collagenase activity and cavernous sinus in human pituitary ademomas. Acta Neurochir, 1996,138:390-395.
  • 9Visse R, Hideaki N. Matrix metalloproteinases and tissue inhibitors of metalloproteinases structure, function and biochemistry. Circ Res ,2003,92 : 827.
  • 10Korbonits M, Goldstone AP, Gueorguiev M, et al. Ghrelin-a hormone with multiple functions. Front Neuroendoerinology ,2004,25:27-68.

共引文献21

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部